IAA - Intranasal insulin and Abatacept trial
The ATIC-led IAA trial has commenced in Melbourne, with clinical trial centres to open in Adelaide, Perth, Brisbane and Sydney.
What does ATIC do?
ATIC is working across six distinct interconnected Domains to ensure maximum impact and fulfil our bold vision.
Clinical trials
Drive the implementation of immunotherapy clinical trials throughout Australia and New Zealand
Community engagement
Work closely with the type 1 diabetes community across the research cycle, from trial development through recruitment to communication of...
Data management
Harmonise data collection and ensure linkage with national and international diabetes networks.
Education and training
Train, equip and update clinicians, scientists and the wider community on the fundamentals of immunotherapy, as well as the latest...
Preclinical and translation
Attract immunotherapy trials to Australasia through innovation: the discovery of improved biomarkers, development of new therapies, and facilitation of biosample...
Regulation and government
Advocate for regulatory approval and government funding of immunotherapy treatments for type 1 diabetes.
Beyond Insulin - April seminar
The next seminar in our Beyond Insulin series will take place Friday the 28th of April from 1pm – 2pm. Dr Ki Wook Kim will provide an overview of the ongoing investigations within the Environmental Determinants of Islet Autoimmunity (ENDIA) study aimed to examine without bias, all viruses (i.e. the virome) and their potential contribution to childhood islet autoimmunity.
Viral aetiology of type 1 diabetes
April 2023
7th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Verapamil in type 1 diabetes
March 2023
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
Continuous glucose monitoring in children at risk of type 1 diabetes
March 2023
6th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
ATIC Town Hall Forum – video now available
February 2023
ATIC recently invited members of the type 1 diabetes community to learn more about ATIC – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments.
We partner with global leaders in our field
Supported by
Coordinating Centre
